MedicineEconomics
S. Grosse
2008.4.1Expert Review of Pharmacoeconomics & Outcomes Research
tlooto Summary
The use of $50,000 as a benchmark for assessing the cost-effectiveness of an intervention first emerged in 1992 and became widely used after 1996, but estimates of willingness to pay and the opportunity cost of healthcare resources are needed.
Abstract
Abstract is not available.
Citation format
GROSSE, S. Assessing cost-effectiveness in healthcare: History of the $50,000 per QALY threshold. Expert Review of Pharmacoeconomics & Outcomes Research, 2008, 8: 165–178.